Ting, Jenny Sweet C.

HRN: 08-14-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/08/2026
08/15/2026
IV
590
Q8
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: